Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Unipolar Major Depression|Stage I, II or III Breast Cancer
Interventions: DRUG: Vortioxetine
Sponsor: University of Miami
Collaborators: Takeda